Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | CAR-T cell therapy: an exciting field in ALL

Nitin Jain • 11 Dec 2017
ASH 2017
Acute Lymphoblastic Leukemia Leukemia CAR-T

One of the current exciting fields in ALL is CAR-T cell therapies. Nitin Jain, MD of the University of Texas MD Anderson Cancer Center, Houston, TX , gives an overview of some of his CAR-T cell therapy highlights from ASH 2017.

More from Nitin Jain

1:54
Nivolumab + ibrutinib for patients with Richter’s transformation
Nitin Jain • 7 Sep 2023
2:04
The evolving role of CAR-T therapy in CLL
Nitin Jain • 7 Sep 2023
1:57
Tackling resistance to CAR-T in ALL
Nitin Jain • 7 Sep 2023
1:59
Novel CAR-T constructs being investigated for the treatment of ALL
Nitin Jain • 7 Sep 2023

Related Videos

5:15
Smoothening the spines: hedgehog signaling inhibitor glasdegib combinations for AML
Jorge Cortes • 5 Mar 2018
3:32
Venetoclax in AML updates: approval & combinations
Marina Konopleva • 18 Dec 2018
2:22
Generic vs. branded imatinib for CP-CML: a multicenter, observational study
Giuseppe Saglio • 17 Dec 2018
1:25
Inotuzumab and blinatumomab: the most exciting ALL news from EHA 2017
David Marks • 24 Jun 2017
The content of VJHemOnc is intended for healthcare professionals